These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 2: Comparative pharmacokinetics of five sulphonamides. Ortengren B, Fellner H, Bergan T. Infection; 1979; 7 Suppl 4():S367-70. PubMed ID: 511350 [Abstract] [Full Text] [Related]
23. Urinary tract infections in Norway: bacterial etiology and susceptibility. A retrospective study of clinical isolates. Grude N, Tveten Y, Kristiansen BE. Clin Microbiol Infect; 2001 Oct; 7(10):543-7. PubMed ID: 11683794 [Abstract] [Full Text] [Related]
24. Sensitivity of enterococci to beta-lactam antibiotics, co-trimoxazole, nitrofurantoin, tetracycline and doxycycline. Grimm H. Arzneimittelforschung; 1983 Oct; 33(3):419-23. PubMed ID: 6603227 [Abstract] [Full Text] [Related]
30. The in vitro activity of ampicillin, amoxicillin, cephalexin, nitrofurantoin, sulphadiazine and trimethoprim against Streptococcus agalactiae isolated from urinary and other infections. Brander P, Jokipii L, Jokipii AM. Infection; 1982 Oct; 10(5):299-302. PubMed ID: 6757138 [Abstract] [Full Text] [Related]
35. [Results with the combination of nitrofurantoin (macrocristalline) and sulphadiazine in chronic urinary tract infections (author's transl)]. Porpáczy P. Wien Klin Wochenschr; 1974 Jan 25; 86(2):50-3. PubMed ID: 4439927 [No Abstract] [Full Text] [Related]
37. Practical aspects of testing sensitivity to trimethoprim and sulphonamide. Waterworth PM. Postgrad Med J; 1969 Nov 25; 45():Suppl:21-9. PubMed ID: 4902846 [No Abstract] [Full Text] [Related]
38. Antimicrobial resistance of urinary isolates in the community and its relation to antibiotic use. Raz R, Hefter H, Oren B, Kennes Y, Potasman I. Isr J Med Sci; 1993 Apr 25; 29(4):207-10. PubMed ID: 8491570 [No Abstract] [Full Text] [Related]